• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconModerna

Moderna

Page 5 of 18
Moderna says its vaccination with booster ‘almost obliterates’ Omicron in the short term
Health
Moderna says its vaccination with booster ‘almost obliterates’ Omicron in the short term
By Chris MorrisJanuary 27, 2022
COVID-19 hospitalizations
Health
Pfizer and Moderna boosters keep you safe from Omicron hospitalization, CDC says
By Fiona Rutherford and BloombergJanuary 21, 2022
Moderna chair says COVID could become flu-like endemic in 2022
Health
Moderna chair says COVID could become flu-like endemic in 2022
By James Paton and BloombergJanuary 14, 2022
A man receives a fourth dose of COVID-19 vaccine at Sheba Medical Center in central Israeli city of Ramat Gan on Dec. 31, 2021.
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022
Photo illustration of Omicron Covid-19 and vaccine needle
Health
Doctor says we need to take Omicron more seriously after detailing his son’s symptoms
By Andrew MarquardtJanuary 10, 2022
Singapore ranks COVID vaccines by death rate—and Moderna comes out on top
Health
Singapore ranks COVID vaccines by death rate—and Moderna comes out on top
By Low De Wei and BloombergJanuary 10, 2022
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By Erika Fry and Nicolas RappJanuary 5, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By Suzi Ring, Naomi Kresge and BloombergDecember 20, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By Lauran Neergaard, Mike Stobbe and The Associated PressDecember 16, 2021
A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
Health
A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
By Christiaan HetznerDecember 16, 2021
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By Erika Fry and Nicolas RappDecember 15, 2021
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...18
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.